Literature DB >> 19066302

Induction of spermatogenesis and fertility during gonadotropin treatment of gonadotropin-deficient infertile men: predictors of fertility outcome.

Peter Y Liu1, H W Gordon Baker, Veena Jayadev, Margaret Zacharin, Ann J Conway, David J Handelsman.   

Abstract

BACKGROUND: The induction of spermatogenesis and fertility with gonadotropin therapy in gonadotropin-deficient men varies in rate and extent. Understanding the predictors of response would inform clinical practice but requires multivariate analyses in sufficiently large clinical cohorts that are suitably detailed and frequently assessed. DESIGN, SETTING, AND PARTICIPANTS: A total of 75 men, with 72 desiring fertility, was treated at two academic andrology centers for a total of 116 courses of therapy from 1981-2008. OUTCOMES: Semen analysis and testicular examination were performed every 3 months.
RESULTS: A total of 38 men became fathers, including five through assisted reproduction. The median time to achieve first sperm was 7.1 months [95% confidence interval (CI) 6.3-10.1]) and for conception was 28.2 months (95% CI 21.6-38.5). The median sperm concentration at conception for unassisted pregnancies was 8.0 m/ml (95% CI 0.2-59.5). Multivariate correlated time-to-event analyses show that larger testis volume, previous treatment with gonadotropins, and no previous androgen use each independently predicts faster induction of spermatogenesis and unassisted pregnancy.
CONCLUSIONS: Larger testis volume is a useful prognostic indicator of response. The association of slower responses after prior androgen therapy suggests that faster pregnancy rates might be achieved by substituting gonadotropin for androgen therapy for pubertal induction, although a prospective randomized trial will be required to prove this.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19066302     DOI: 10.1210/jc.2008-1648

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  51 in total

Review 1.  Neonatal gonadotropin therapy in male congenital hypogonadotropic hypogonadism.

Authors:  Claire Bouvattier; Luigi Maione; Jérôme Bouligand; Catherine Dodé; Anne Guiochon-Mantel; Jacques Young
Journal:  Nat Rev Endocrinol       Date:  2011-10-18       Impact factor: 43.330

2.  Lack of Improvement of Sperm Characteristics in Obese Males After Obesity Surgery Despite the Beneficial Changes Observed in Reproductive Hormones.

Authors:  Antonia Martín-Hidalgo; José I Botella-Carretero; Berniza Calderón; Lydia Huerta; Julio Galindo; José Manuel González Casbas; Héctor F Escobar-Morreale
Journal:  Obes Surg       Date:  2019-07       Impact factor: 4.129

3.  An update on male hypogonadism therapy.

Authors:  Prasanth Surampudi; Ronald S Swerdloff; Christina Wang
Journal:  Expert Opin Pharmacother       Date:  2014-04-23       Impact factor: 3.889

4.  Gonadotropin replacement in male thalassemia major patients with arrested puberty and acquired hypogonadotropic hypogonadism (AAH): preliminary results and potential factors affecting induction of spermatogenesis.

Authors:  Vincenzo De Sanctis; Ashraf T Soliman; Duran Canatan; Salvatore Di Maio; Heba Elsedfy; Alaa Baioumi; Christos Kattamis
Journal:  Endocrine       Date:  2018-10-08       Impact factor: 3.633

Review 5.  The silent spermatozoon: are man-made endocrine disruptors killing male fertility?

Authors:  Bradley D Anawalt
Journal:  Asian J Androl       Date:  2013-01-21       Impact factor: 3.285

Review 6.  Approach to male infertility and induction of spermatogenesis.

Authors:  Bradley D Anawalt
Journal:  J Clin Endocrinol Metab       Date:  2013-09       Impact factor: 5.958

7.  Efficacy of recombinant human follicle stimulating hormone at low doses in inducing spermatogenesis and fertility in hypogonadotropic hypogonadism.

Authors:  A A Sinisi; D Esposito; G Bellastella; L Maione; V Palumbo; L Gandini; F Lombardo; A De Bellis; A Lenzi; A Bellastella
Journal:  J Endocrinol Invest       Date:  2010-04-30       Impact factor: 4.256

8.  Dose-dependent increase in intratesticular testosterone by very low-dose human chorionic gonadotropin in normal men with experimental gonadotropin deficiency.

Authors:  M Y Roth; S T Page; K Lin; B D Anawalt; A M Matsumoto; C N Snyder; B T Marck; W J Bremner; J K Amory
Journal:  J Clin Endocrinol Metab       Date:  2010-05-19       Impact factor: 5.958

9.  Outcome of gonadotropin therapy for male infertility due to hypogonadotrophic hypogonadism.

Authors:  Rafif Farhat; Fatma Al-zidjali; Ali S Alzahrani
Journal:  Pituitary       Date:  2010-06       Impact factor: 4.107

10.  Serum insulin-like factor 3 is highly correlated with intratesticular testosterone in normal men with acute, experimental gonadotropin deficiency stimulated with low-dose human chorionic gonadotropin: a randomized, controlled trial.

Authors:  Mara Y Roth; Kat Lin; Katrine Bay; John K Amory; Bradley D Anawalt; Alvin M Matsumoto; Brett T Marck; William J Bremner; Stephanie T Page
Journal:  Fertil Steril       Date:  2012-10-03       Impact factor: 7.329

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.